menu
    • menu

    Company profile for CHARM Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded by leaders with a track record in next-wave AI, with a culture of excellence and innovation at its heart and a commitment to delivery.We are an entrepreneurial team of extraordinary scientists, engineers and entrepreneurs, purpose-built to meld cutting edge know-how from 3D deep learning and drug discovery.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CHARM Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    7 Pancras Sq London N1C 4AG
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://charmtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/charm-therapeutics/?originalSubdomain=uk
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/charmtherapeutx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Charm Therapeutics Advances Chm-029 for Acute Myeloid Leukaemia
    Charm Therapeutics Advances Chm-029 for Acute Myeloid Leukaemia

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187132/0/en/CHARM-Therapeutics-advances-CHM-029-a-next-generation-menin-inhibitor-designed-to-overcome-resistance-mutations-as-its-first-clinical-candidate-for-acute-myeloid-leukaemia-AML.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    CHARM Therapeutics Names Dr Erkut Bahceci Chief Medical Officer
    CHARM Therapeutics Names Dr Erkut Bahceci Chief Medical Officer

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3145810/0/en/CHARM-Therapeutics-Appoints-Dr-Erkut-Bahceci-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share
    CHARM Secures $80M Series B for Menin Inhibitor AML Development
    CHARM Secures $80M Series B for Menin Inhibitor AML Development

    02 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/02/3142466/0/en/CHARM-Therapeutics-raises-80-million-in-Series-B-financing-to-advance-development-of-best-in-class-menin-inhibitor-for-AML.html

    GLOBENEWSWIRE
    02 Sep 2025
    Share Share
    CHARM Therapeutics Appoints Dr. Beverley Carr As Chief Officer
    CHARM Therapeutics Appoints Dr. Beverley Carr As Chief Officer

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943485/0/en/CHARM-Therapeutics-appoints-Dr-Beverley-Carr-as-Chief-Business-Officer.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    CHARM Appoints Dr. Nicholas Edmunds as Chief Development Officer
    CHARM Appoints Dr. Nicholas Edmunds as Chief Development Officer

    30 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/30/2872031/0/en/CHARM-Therapeutics-appoints-Dr-Nicholas-Edmunds-as-Chief-Development-Officer-Head-of-Pre-Clinical-Development.html

    GLOBENEWSWIRE
    30 Apr 2024
    Share Share
    CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
    CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)

    19 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/19/2848692/0/en/CHARM-Therapeutics-Announces-Foundation-of-Scientific-Advisory-Board-SAB.html

    GLOBENEWSWIRE
    19 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search